LONDON: DeepMatter Group, company focusing on digitising chemistry, has signed a contract with the Cancer Research UK Beatson Institute and Cancer Research Technology (the commercialisation and development arm of Cancer Research UK) for its DigitalGlassware platform. The technology will be installed within the institute’s Drug Discovery Unit to enable the accurate and reproducible sharing of…